Successful treatment with infliximab despite positive tuberculosis ELISpot results in a patient with pityriasis rubra pilaris taking prophylactic isoniazid

Clinical and Experimental Dermatology

Volumn 36, Issue 7, 2011, Pages 808-809

  Zirbs, M ^a   Kigitsidou, E ^a   Seifert, F ^a   Ring, J ^a   Brockow, K ^a  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

INFLIXIMAB; ISONIAZID;

ADULT; CASE REPORT; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; ENZYME LINKED IMMUNOSPOT ASSAY; HISTOPATHOLOGY; HUMAN; LETTER; MALE; PALMOPLANTAR KERATODERMA; PAPULE; PITYRIASIS RUBRA PILARIS; PRIORITY JOURNAL; PROPHYLAXIS; TREATMENT OUTCOME; TUBERCULOSIS;

ANTI-INFLAMMATORY AGENTS; ANTIBODIES, MONOCLONAL; ANTITUBERCULAR AGENTS; HUMANS; ISONIAZID; MALE; MIDDLE AGED; PITYRIASIS RUBRA PILARIS; TREATMENT OUTCOME; TUBERCULOSIS;

EID: 80052968495     PISSN: 03076938     EISSN: 13652230     Source Type: Journal    
DOI: 10.1111/j.1365-2230.2011.04074.x     Document Type: Letter

References (5)

1. Klein A, Landthaler M, Karrer S,. Pityriasis rubra pilaris: a review of diagnosis and treatment. Am J Clin Dermatol 2010; 11: 157-70.
2. Keane J, Gershon S, Wise RP, et al. Tuberculosis associated with infliximab, a tumor necrosis factor alpha-neutralizing agent. N Engl J Med 2001; 345: 1098-104.
3. Menzies D, Pai M, Comstock G,. Meta-analysis: new tests for the diagnosis of latent tuberculosis infection: areas of uncertainty and recommendations for research. Ann Intern Med 2007; 146: 340-54. (Pubitemid 351650594)
4. Laffitte E, Janssens JP, Roux-Lombard P, et al. Tuberculosis screening in patients with psoriasis before antitumour necrosis factor therapy: comparison of an interferon-gamma release assay vs. tuberculin skin test. Br J Dermatol 2009; 161: 797-800.
5. Gardam MA, Keystone EC, Menzies R, et al. Anti-tumour necrosis factor agents and tuberculosis risk: mechanisms of action and clinical management. Lancet Infect Dis 2003; 3: 148-55. (Pubitemid 36278124)